# Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma

> **NCT01583543** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 12 (actual)

## Conditions studied

- Ewing's Sarcoma

## Interventions

- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT01583543
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-01
- **Final completion:** 2014-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01583543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01583543, "Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01583543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*